Literature DB >> 29711846

Cu2+ Inhibits the Aggregation of Amyloid β-Peptide(1-42) in vitro.

Jin Zou1, Katsushi Kajita1, Naoki Sugimoto1.   

Abstract

A distinct biochemical role of Cu2+ as an inhibitor in the aggregation of the peptide Aβ(42) in vitro was revealed by thioflavin T fluorescence assay and atomic force microscopy. The Cu2+ -Aβ(42) complex is responsible for the inhibition because it stabilizes the soluble form of Aβ(42) and controls the conformational transition ([Eq. (1)]; ki =[Aβ(42)][Cu2+ ]/[Cu2+ -Aβ(42)]).
© 2001 WILEY-VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany.

Entities:  

Keywords:  aggregation; copper; inhibitors; peptides

Year:  2001        PMID: 29711846     DOI: 10.1002/1521-3773(20010618)40:12<2274::AID-ANIE2274>3.0.CO;2-5

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  3 in total

1.  Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease.

Authors:  Luc Guilloreau; Luminita Damian; Yannick Coppel; Honoré Mazarguil; Mathias Winterhalter; Peter Faller
Journal:  J Biol Inorg Chem       Date:  2006-08-22       Impact factor: 3.358

2.  Cu(II) mediates kinetically distinct, non-amyloidogenic aggregation of amyloid-beta peptides.

Authors:  Jeppe T Pedersen; Jesper Østergaard; Noemi Rozlosnik; Bente Gammelgaard; Niels H H Heegaard
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

3.  Discovery of Novel Drug Candidates for Alzheimer's Disease by Molecular Network Modeling.

Authors:  Jiaxin Zhou; Qingyong Li; Wensi Wu; Xiaojun Zhang; Zhiyi Zuo; Yanan Lu; Huiying Zhao; Zhi Wang
Journal:  Front Aging Neurosci       Date:  2022-04-15       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.